Who owns Innate Pharma Adr?
- Ticker: IPHA
- CUSIP Number: 45781k204
Tip: Access positions for across all investors
Analyze quarterly positions in Innate Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Innate Pharma stock
Who bought or sold Innate Pharma Adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Morgan Stanley | 51k | $93k | 100% | Jun 2025 |
|
| Citadel Advisors | 20k | $39k | -25% | Sep 2025 |
|
| UBS Group | 4.8k | $9.3k | -19% | Sep 2025 |
|
| GAMMA Investing | 2.3k | $4.4k | -34% | Sep 2025 |
|
| Rhumbline Advisers | 470.00 | $915.983000 | 0% | Sep 2025 |
|
| Barclays | 307.00 | $593.001200 | 0% | Sep 2025 |
|
| Optiver Holding B.V. | 101.00 | $197.000500 | 0% | Sep 2025 |
|
| Principal Securities | 45.00 | $86.998500 | 0% | Sep 2025 |
|
| Farther Finance Advisors | 10.00 | $19.000000 | 100% | Sep 2025 |
|
Who sold out of Innate Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2025 | 12k | $20k |